Navigation Links
Deblistering Device Keeps Production Ahead Of Pack
Date:9/24/2009

The increased need for pharmaceutical packaging companies to reduce waste and disposal costs in a way that minimises the impact on the environment has led to an increased demand for specialised deblistering machines according to the specialist pharma-packaging machinery manufacturer Sepha. The machines, called Press-Outs, are used to increase production yields by recovering valuable product from the line. In response to the demand, Sepha will be taking Press-Outs on tour around the world at major exhibitions in the USA, Europe and Asia commencing with Packtech Expo Balkan in Belgrade on 23 September followed by Fachpack in Nuremburg, Germany, Pack Expo in Las Vegas, Scanpack in Sweden and China Pharm in Shanghai in October and PMEC in Mumbai, India in December.

Belfast (Vocus) September 24, 2009 -- The increased need for pharmaceutical packaging companies to reduce waste and disposal costs in a way that minimises the impact on the environment has led to an increased demand for specialised deblistering machines according to Sepha. The machines, called Press-Outs, are used to increase production yields by recovering valuable product from the line. They enable the easy removal of tablets from rejected blister packs, so they can be re-packaged again. In response to growing demand, Sepha will be taking Press-Outs on tour around the world at major exhibitions in the USA, Europe and Asia commencing with Packtech Expo Balkan in Belg
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
2. NIH grants $750,000 to develop device to determine temperature of neonates brain
3. IBM and Imago find a crucial difficulty in semiconductor device scaling
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers
6. Researchers improve ability to write and store information on electronic devices
7. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
8. Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family
9. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
10. Valeritas Hires Trade and Distribution Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
11. Doping technique brings nanomechanical devices into the semiconductor world
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Deblistering Device Keeps Production Ahead Of Pack
(Date:3/5/2015)... NEW YORK , March 5, 2015  DuPont ... J.P. Morgan Aviation, Transportation and Industrials Conference held today ... Vice President Matthew L. Trerotola discussed strategy, ... Advanced Materials segments for DuPont.  Strengthening and growing the ... of the three areas of strategic priority for DuPont. ...
(Date:3/5/2015)... BioPlus Specialty Pharmacy (BioPlus) announces the ... President of Managed Care. In this role, Damm will ... the nation’s leading specialty pharmacies. , Damm, who is ... specialty pharmacy and biotech experience to his new position ... Pharmaceuticals, and Pfizer. Prior to working in Healthcare Damm ...
(Date:3/5/2015)... and Markets ( http://www.researchandmarkets.com/research/4ld5nw/mature_biotech ) has announced ... New Therapy Ventures Pave the Way for Success" ... companies - Gilead (GILD), Amgen (AMGN), Biogen Idec (BIIB) ... positive return and hence increased the interest of biotech ... indication where the high treatment cost justifies the need. ...
(Date:3/4/2015)... PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) today ... , 3.75% Convertible Senior Notes due May 1, 2015 (May ... principal amount or approximately $5.72 per share, effective March 3, 2015. ... adjusted in connection with the regular quarterly dividend of $0.15 ... own shares of PDL on March 5, 2015, the record date. ...
Breaking Biology Technology:DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 2DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 3DuPont Leader Highlights Strategy, Progress and Plans to Accelerate Growth in Advanced Materials and Discusses Near-Term Outlook 4BioPlus Specialty Pharmacy Announces Hiring of New Vice President of Managed Care: Jamie Damm 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2
... WALTHAM, Mass., Nov. 10, 2011 Interleukin Genetics, Inc. ... the third quarter ended September 30, 2011. Total ... $765,000, compared to $545,000 for the same period in the ... revenue. Research and development expenses were $325,000 ...
... Inc., a global, full-service testing laboratory with more than ... organs, cells, tissues and implantable biologic products and devices, ... private companies, as judged by the annual ColoradoBiz ... Top 250 Private Companies list is an annual ranking ...
... England Biolabs (NEB), in its continuing commitment to open ... database covering DNA polymerase biochemistry, genetics and structural biology. ... and maintained by NEB), Polbase summarizes the information that ... it easy for researchers to interrogate and use. Polbase ...
Cached Biology Technology:Interleukin Genetics Reports Third Quarter 2011 Financial Results 2Interleukin Genetics Reports Third Quarter 2011 Financial Results 3Interleukin Genetics Reports Third Quarter 2011 Financial Results 4LABS, Inc. Among Colorado's Top Private Companies 2New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers 2
(Date:2/5/2015)... OXFORD, Conn. , Jan. 28, 2015 ... ("NXT-ID" or the "Company"), a biometric authentication company focused ... present at the upcoming RedChip Global Online CEO Conference ... Gino Pereira , CEO of ... discussing its lead product, the Wocket smart wallet and ...
(Date:1/22/2015)... Jan. 9, 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), ... general the State of Washington,s Department ... new enrollment and central issuance system for driver,s licenses and ... The project planning and development will start in January 2015, ...
(Date:1/22/2015)... man-made form of insulin delivered by nasal spray may ... with mild cognitive impairment and Alzheimer,s disease dementia, according ... Forest Baptist Medical Center. The study,s subjects ... (MCI) or mild to moderate Alzheimer,s dementia (AD). Those ...
Breaking Biology News(10 mins):CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... San Diego, Calif. Glioblastoma, the most common and lethal ... because the tumors rapidly become resistant to therapy. As cancer ... growth and drug resistance, they are discovering molecular pathways that ... deadly cancer. Scientists at the Ludwig Institute for Cancer ...
... at the Society of Toxicology,s Annual Meeting and ToxExpo ... that have received growing public attention over the past ... explore how the development of an epidemiological database that ... risk assessment of arsenic in food. While epidemiological studies ...
... Vision and Ophthalmology 2013 Annual Meeting will feature lectures ... the organization,s five-day conference, May 5 9 in ... Series will include Oliver Smithies, DPhil; Roger Tsien, PhD ... University of North Carolina at Chapel Hill, is a ...
Cached Biology News:Novel combination therapy shuts down escape route, killing glioblastoma tumor cells 2Scientists explore topical health issues at meeting in Texas 23 distinguished keynote speakers to present during ARVO 2013 Annual Meeting 2
...
...
... Comments: Ab-1 stains tumor cells of embryonal carcinoma ... of germ cell tumors like seminoma. Glandular epithelium ... positive. Luminal and endocrine cells of stomach and ... are also positive. Epitope: Carbohydrate portion ...
TP-1 (NDOG1)...
Biology Products: